Edition:
India

Evoke Pharma Inc (EVOK.OQ)

EVOK.OQ on NASDAQ Stock Exchange Capital Market

2.02USD
2:29am IST
Change (% chg)

$0.01 (+0.50%)
Prev Close
$2.01
Open
$2.05
Day's High
$2.05
Day's Low
$1.96
Volume
14,198
Avg. Vol
39,338
52-wk High
$4.09
52-wk Low
$1.95

Chart for

About

Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in... (more)

Overall

Beta: 1.24
Market Cap(Mil.): $55.71
Shares Outstanding(Mil.): 15.39
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-‍Mr Green Acquires Evoke Gaming Including Redbet​

* ‍PURCHASE PRICE OF EUR 7 MILLION IN CASH; AN ADDITIONAL PURCHASE PRICE OF EUR 1.5 MILLION MAY BE PAYABLE IF CERTAIN CONDITIONS ARE MET​

19 Dec 2017

BRIEF-Evoke Pharma reports Q3 loss per share $0.34

* Evoke Pharma reports third quarter 2017 results and highlights

15 Nov 2017

BRIEF-Evoke Pharma signs commercial agreement with Thermo Fisher Scientific

* Announced selection of Patheon division of Thermo Fisher Scientific as commercial manufacturing partner for Gimoti​

09 Nov 2017

BRIEF-Evoke Pharma reports positive topline results from comparative exposure pharmacokinetic study for gimoti

* Evoke Pharma announces positive topline results from comparative exposure pharmacokinetic study for gimoti™

23 Oct 2017

BRIEF-Evoke pharma completes dosing for Gimoti™comparative exposure Pharmacokinetic study

* Evoke pharma completes dosing for Gimoti™ comparative exposure Pharmacokinetic study

12 Sep 2017

Competitors

Earnings vs. Estimates